These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29800694)

  • 1. Withdrawal of parathyroid hormone after prolonged administration leads to adipogenic differentiation of mesenchymal precursors in vivo.
    Balani DH; Kronenberg HM
    Bone; 2019 Jan; 118():16-19. PubMed ID: 29800694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
    Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
    FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone regulates fates of murine osteoblast precursors in vivo.
    Balani DH; Ono N; Kronenberg HM
    J Clin Invest; 2017 Sep; 127(9):3327-3338. PubMed ID: 28758904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid Hormone Shifts Cell Fate of a Leptin Receptor-Marked Stromal Population from Adipogenic to Osteoblastic Lineage.
    Yang M; Arai A; Udagawa N; Zhao L; Nishida D; Murakami K; Hiraga T; Takao-Kawabata R; Matsuo K; Komori T; Kobayashi Y; Takahashi N; Isogai Y; Ishizuya T; Yamaguchi A; Mizoguchi T
    J Bone Miner Res; 2019 Oct; 34(10):1952-1963. PubMed ID: 31173642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Gsα early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors.
    Sinha P; Aarnisalo P; Chubb R; Ono N; Fulzele K; Selig M; Saeed H; Chen M; Weinstein LS; Pajevic PD; Kronenberg HM; Wu JY
    J Bone Miner Res; 2014 Nov; 29(11):2414-26. PubMed ID: 24806274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
    Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
    Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway.
    Zhou X; Liu Z; Huang B; Yan H; Yang C; Li Q; Jin D
    Drug Des Devel Ther; 2019; 13():2703-2713. PubMed ID: 31496649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.
    Casado-Diaz A; Santiago-Mora R; Quesada JM
    Exp Mol Med; 2010 Feb; 42(2):87-98. PubMed ID: 19946180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.
    Fan Y; Hanai JI; Le PT; Bi R; Maridas D; DeMambro V; Figueroa CA; Kir S; Zhou X; Mannstadt M; Baron R; Bronson RT; Horowitz MC; Wu JY; Bilezikian JP; Dempster DW; Rosen CJ; Lanske B
    Cell Metab; 2017 Mar; 25(3):661-672. PubMed ID: 28162969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
    Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
    Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
    Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
    PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP signaling in bone marrow stromal cells has reciprocal effects on the ability of mesenchymal stem cells to differentiate into mature osteoblasts versus mature adipocytes.
    Kao R; Lu W; Louie A; Nissenson R
    Endocrine; 2012 Dec; 42(3):622-36. PubMed ID: 22695986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by a Phytoestrogen Diarylheptanoid from
    Sutjarit N; Thongon N; Weerachayaphorn J; Piyachaturawat P; Suksamrarn A; Suksen K; Papachristou DJ; Blair HC
    J Agric Food Chem; 2020 Sep; 68(37):9993-10002. PubMed ID: 32838526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts.
    Kim SW; Pajevic PD; Selig M; Barry KJ; Yang JY; Shin CS; Baek WY; Kim JE; Kronenberg HM
    J Bone Miner Res; 2012 Oct; 27(10):2075-84. PubMed ID: 22623172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 Facilitates the Human Mesenchymal Stem Cell Osteo-Adipogenic Balance.
    Yu C; Peall IW; Pham SH; Okolicsanyi RK; Griffiths LR; Haupt LM
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration.
    Ogita M; Rached MT; Dworakowski E; Bilezikian JP; Kousteni S
    Endocrinology; 2008 Nov; 149(11):5713-23. PubMed ID: 18617606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin Antibody Administration Increases the Numbers of Sox9creER+ Skeletal Precursors and Their Progeny.
    Balani DH; Trinh S; Xu M; Kronenberg HM
    J Bone Miner Res; 2021 Apr; 36(4):757-767. PubMed ID: 33400836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.